ARDELYX INC (ARDX) — insider trading
Health Care · NASDAQ
ARDELYX INC (ARDX) has 26 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 26 (latest 2026-06-18).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | Williams Laura A | Officer (Chief Patient Officer) | Option exercise / conversion (derivative) | 31,000 | $0.00 | $0 | Form 4 |
| 2026-06-18 | Williams Laura A | Officer (Chief Patient Officer) | Open-market sale | 81,898 | $5.99 | $490.5K | Form 4 |
| 2026-06-18 | Williams Laura A | Officer (Chief Patient Officer) | Option exercise / conversion | 31,000 | $0.99 | $30.7K | Form 4 |
| 2026-06-16 | Bazemore Robert B | Director | Grant / award / vesting (derivative) | 39,715 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Bazemore Robert B | Director | Grant / award / vesting | 26,455 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Bertrand William C JR | Director | Grant / award / vesting (derivative) | 39,715 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Bertrand William C JR | Director | Grant / award / vesting | 26,455 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Bertrand William C JR | Director | Grant / award / vesting | 12,345 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Bhanji Muna | Director | Grant / award / vesting (derivative) | 39,715 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Bhanji Muna | Director | Grant / award / vesting | 26,455 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Cadoret-Manier Onaiza | Director | Grant / award / vesting (derivative) | 39,715 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Cadoret-Manier Onaiza | Director | Grant / award / vesting | 26,455 | $0.00 | $0 | Form 4 |
| 2026-06-16 | MOTT DAVID M | Director | Grant / award / vesting (derivative) | 39,715 | $0.00 | $0 | Form 4 |
| 2026-06-16 | MOTT DAVID M | Director | Grant / award / vesting | 26,455 | $0.00 | $0 | Form 4 |
| 2026-06-16 | MOTT DAVID M | Director | Grant / award / vesting | 20,282 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Rodgers Richard J | Director | Grant / award / vesting (derivative) | 39,715 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Rodgers Richard J | Director | Grant / award / vesting | 26,455 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Parsey Merdad | Director | Grant / award / vesting (derivative) | 39,715 | $0.00 | $0 | Form 4 |
| 2026-06-16 | Parsey Merdad | Director | Grant / award / vesting | 26,455 | $0.00 | $0 | Form 4 |
| 2026-06-15 | RAAB MICHAEL | Director, Officer (President & CEO) | Option exercise / conversion (derivative) | 20,833 | $0.00 | $0 | Form 4 |
| 2026-06-15 | RAAB MICHAEL | Director, Officer (President & CEO) | Open-market sale | 41,666 | $5.67 | $236.3K | Form 4 |
| 2026-06-15 | RAAB MICHAEL | Director, Officer (President & CEO) | Option exercise / conversion | 20,833 | $0.99 | $20.6K | Form 4 |
| 2026-05-21 | Bishop John E | Officer (See Remarks) | Open-market sale | 2,306 | $6.27 | $14.5K | Form 4 |
| 2026-05-21 | Hohenleitner Susan | Officer (Chief Financial Officer) | Open-market sale | 1,455 | $6.27 | $9.1K | Form 4 |
| 2026-05-21 | Reilly Joseph James | Officer (See Remarks) | Open-market sale | 1,036 | $6.27 | $6.5K | Form 4 |
| 2026-05-21 | Reilly Joseph James | Officer (See Remarks) | Open-market sale | 2,683 | $6.27 | $16.8K | Form 4 |
Ask the chat about ARDX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ARDELYX INC (ARDX).
Last updated 2026-06-18 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.